Multi Caps
Multi Caps, licence 02245766: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Flora Manufacturing & Distributing Ltd
- NPN or DIN-HM
- 02245766
- Status
- Active licence
- Licence date
- 9 September 2009
- Revision date
- 17 September 2013
- Form
- Capsule
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine D: up to 10 µg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 50 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B12 Source : Cyanocobalamine | 25.0 µg | 50 µg |
| Vitamine C Source : Acide ascorbique | 75.0 mg | 150,000 µg |
| Magnésium Source : Produit de chélation de magnésium et de protéine végétale hydrolysée (PVH) | 35.0 mg | 70,000 µg |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 25.0 mg | 50,000 µg |
| Vitamine E Source : Acétate de d-alpha-tocophéryle Potency : 35.0 UI | 23.0 mg AT | Not calculated |
| Vitamine A Source : Palmitate de vitamine A Potency : 4000.0 UI | 1209.0 µg RAE | Not calculated |
| Folate Source : Folate | 250.0 µg | Not calculated |
| Choline Source : Bitartrate de choline | 25.0 mg | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 200.0 UI | 5.0 µg | 10 µg |
| Thiamine Source : Chlorhydrate de thiamine | 25.0 mg | 50,000 µg |
| Riboflavine Source : Riboflavine | 25.0 mg | 50,000 µg |
| Acide pantothénique Source : D-pantothénate de calcium | 25.0 mg | 50,000 µg |
| Calcium Source : Produit de chléation de calcium et de PVH | 62.5 mg | 125,000 µg |
Non-medicinal ingredients
Bioflavonoïdes d'agrumes, Dioxyde de silicium, phosphate de dicalcium, Hespéridine, papaïne, Para-Aminobenzoic Acid, Stéarate de magnésium, Hypromellose, Chlorhydrate d'acide glutamique, Microcrystalline cellulose, Rutine, Chlorhydrate de bétaïne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
A source of antioxidants for the maintenance of good health. Helps in wound healing. Assists the body to metabolize carbohydrates, proteins and fats. Helps in the absorption and use of calcium and phosphorus. Supports red blood cells, tissue and connective tissue formation. Helps in the maintenance of eyesight, night vision, skin, bones, cartilage, teeth, gums, membranes and immune function. Helps in the function of the thyroid gland. Provides support for healthy glucose metabolism. Reduces the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02245766
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2013. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.